Shojiro Ichimata

Dr. Shojiro Ichimata

Legal Medicine, University of Toyama, Toyama, Japan
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in Amyloid
Verified
Journal Article
Closed access
SIShojiro Ichimata
Shojiro Ichimata
YHYukiko Hata
Yukiko Hata
KHKeiichi Hirono
Keiichi Hirono
YYYoshiaki Yamaguchi
Yoshiaki Yamaguchi
NNNaoki Nishida
Naoki Nishida
To investigate the clinicopathological features of sporadic amyloid transthyretin (ATTR) amyloidosis.We evaluated 1698 serial Japanese forensic autopsy patients. The extent and amount of ATTR depos...

1 April 2023 in Translational Neurodegeneration
Verified
Journal Article
Open access
PDF file
KYKoji Yoshida
Koji Yoshida
YHYukiko Hata
Yukiko Hata
SIShojiro Ichimata
Shojiro Ichimata
KOKeitaro Okada
Keitaro Okada
NNNaoki Nishida
Naoki Nishida
Background: Neuropathological diagnosis of argyrophilic grain disease (AGD) is currently based primarily on the combination of argyrophilic grain (AG) visualized using Gallyas–Braak silver staining, phosphorylated tau-positive pretangles, coiled bodies, and ballooned neuron detection. Although AGD is common in patients with dementia and/or prominent psychiatric symptoms, whether it is a distinct neurological disease entity or a by-product of the aging process remains unclear. Methods: In 1449 serial forensic autopsy cases > 40 years old (823 males and 525 females, aged 40–101 years, mean age 70.0 ± 14.1 years), we examined the frequency and comorbid pathology of AGD cases and investigated the clinical appearance by comparing those with non-AGD cases using the propensity score. Results: Of the 1449 cases, we detected 342 AGD cases (23.6%; mean age 79.7 years; 177 males and 165 females). The AGD frequency and stage increased with age (P < 0.001). Among AGD cases, 80 (23.4%) patients had dementia, and 51 (15.2%) had a history of psychiatric hospital visits. The frequency of suicide and history of psychiatric disorders were significantly higher in AGD cases than in AGD-negative cases, matched for age, sex, and comorbidity pathology, with a relative risk of suicide of 1.72 (1.30–2.26). The frequency of suicide was significantly higher in AGD cases than in non-AGD cases in female but not male cases. The relative risk of suicide increased to 2.27 (1.20–4.30) and 6.50 (1.58–26.76) in AGD patients with Lewy and progressive supranuclear palsy pathology, respectively, and decreased to 0.88 (0.38–2.10) in those with advanced AD pathology. In AGD cases, 23.4% had dementia; however, the difference was not significant after controlling for age, sex, and comorbid pathology. Conclusion: Our study demonstrated that AGD is a significant and isolated risk factor for psychiatric hospital visits and suicide completion. In older adults, AGs may contribute to the progression of functional impairment of the limbic system, which leads to psychiatric disorders and suicide attempts.

17 May 2022 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SIShojiro Ichimata
Shojiro Ichimata
KYKoji Yoshida
Koji Yoshida
NVNaomi P Visanji
Naomi P Visanji
ALAnthony E Lang
Anthony E Lang
NNNaoki Nishida
Naoki Nishida
GKGabor G Kovacs
Gabor G Kovacs
Background: Down syndrome (DS) is frequently associated with Alzheimer’s disease (AD)-related neuropathological changes. There are few observations on the spectrum of mixed proteinopathies in DS patients. Objective: This study aimed to evaluate multiple disease-associated proteinopathies in a series of DS cases. Methods: We analyzed the distribution of neurodegenerative disease associated proteins in postmortem brain samples from 11 DS cases (6 females, median age 57, range 38–66 years). Sections were stained for phosphorylated tau, 3-repeat and 4-repeat tau, amyloid-β, alpha synuclein, phosphorylated TDP-43, and p62. A comprehensive anatomical mapping and staging were applied for all proteins. Results: Tau and amyloid-β pathology was prevalent in all cases and compatible with that typically seen in AD with some subtle deviations. Four of 11 cases presented with Lewy-related pathology (LRP). Two cases followed the Braak staging (stage 4 and 5) whereas 2 cases presented with an atypical distribution. Two cases showed limbic predominant age-related TDP-43 encephalopathy (LATE) (stage 1 and stage 2) neuropathologic change. Two cases exhibited aging-related tau astrogliopathy (ARTAG). Conclusion: In addition to subtle deviations from AD regarding the morphology of amyloid-β deposition and distribution of neuronal tau pathology, we find that the spectrum of mixed-pathologies in DS show distinctive features such as deviations from the Braak staging of LRP and that LATE neuropathologic change and ARTAG pathology can be seen in individuals younger than in sporadic AD cases. Our observations support the notion that DS has distinctive pathogenic pathways from sporadic AD.

Verified
Journal Article
Open access
PDF file
YHYukiko Hata
Yukiko Hata
SIShojiro Ichimata
Shojiro Ichimata
YYYoshiaki Yamaguchi
Yoshiaki Yamaguchi
KHKeiichi Hirono
Keiichi Hirono
YOYuko Oku
Yuko Oku
NNNaoki Nishida
Naoki Nishida
Myocyte disarray of >10% in the heart is broadly accepted as a diagnostic pitfall for hypertrophic cardiomyopathy (HCM) at postmortem. The present study aims to propose an additional diagnostic criterion of HCM. Heart specimens from 1387 serial forensic autopsy cases were examined. Cases with myocyte disarray were extracted and applied to morphometric analysis to determine the amount of myocyte disarray. Comprehensive genetic analysis by using next-generation sequencing was subsequently applied for cases with myocyte disarray. Fifteen cases with myocyte disarray were extracted as candidate cases (1.1%, 11 men and 4 women, aged 48–94 years). In terms of the cause of death, only 2 cases were cardiac or possible cardiac death, and the other was non-cardiac death. Six cases showed myocyte disarray of >10% and 3 cases showed myocyte disarray of 5% to 10%. The other 6 cases showed myocyte disarray of 5%. The remaining 1 and 6 cases with myocyte disarray of 5% with rare variants in related genes might be an appropriate postmortem diagnostic criterion for HCM, in addition to myocyte disarray of 10%.

1 December 2015 in Pathology - Research and Practice
Verified
Journal Article
Closed access
TMTakashi Muraki
Takashi Muraki
TUTakeshi Uehara
Takeshi Uehara
KSKenji Sano
Kenji Sano
HOHiroyoshi Oota
Hiroyoshi Oota
AYAkihiko Yoshizawa
Akihiko Yoshizawa
ETEiji Tanaka
Eiji Tanaka

21 January 2020 in Neuropathology
Verified
Journal Article
Closed access
PDF file
SIShojiro Ichimata
Shojiro Ichimata
YHYukiko Hata
Yukiko Hata
KYKoji Yoshida
Koji Yoshida
NNNaoki Nishida
Naoki Nishida